Prostate Cancer Reports


Volume 1 Number 12
 December 2013

Home > Prostate Cancer Reports > Volume 1 - Year 2013 Number 12, December 2013

CONTENTS


Overviews
Topics
Localized PCa
Advanced PCa


OVERVIEWS

Tefekli A, Tunc M, Tugcu V, Esen T.
Prostate cancer: all aspects.
ScientificWorldJournal. 2013 Oct 1;2013:265234. doi: 10.1155/2013/265234.
Abstract | Full text | Related citations


Guidelines

Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N.
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013.
Eur Urol. 2014 Jan;65(1):124-37. doi: 10.1016/j.eururo.2013.09.046. Epub 2013 Oct 6.
Abstract | Related citations


Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N.
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer.
Eur Urol. 2013 Nov 12. pii: S0302-2838(13)01199-8. doi: 10.1016/j.eururo.2013.11.002. [Epub ahead of print]
Abstract | Full text | Related citations

TOPICS

Integrative medicine

*

Discacciati A, Orsini N, Wolk A.
Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer--a dose-response meta-analysis.
Ann Oncol. 2013 Nov 24. [Epub ahead of print]
Abstract | Full text | Related citations


Parsons JK, Marshall JR, Nelson H.
Does altering diet affect progression of prostate cancer? The MEAL study.
Bull Am Coll Surg. 2013 Oct;98(10):57-9.
Abstract | Full text | Related citations


 Statins


Mucci LA, Stampfer MJ.
Mounting Evidence for Prediagnostic Use of Statins in Reducing Risk of Lethal Prostate Cancer.
J Clin Oncol. 2013 Nov 25. [Epub ahead of print]
Abstract | Full text | Related citations


Jespersen CG, Nørgaard M, Friis S, Skriver C, Borre M.
Statin use and risk of prostate cancer: A Danish population-based case-control study, 1997-2010.
Cancer Epidemiol. 2013 Nov 22. pii: S1877-7821(13)00170-7. doi: 10.1016/j.canep.2013.10.010. [Epub ahead of print]
Abstract | Related citations


Phillips R.
Prostate cancer: Statins reduce mortality risk.
Nat Rev Urol. 2013 Dec;10(12):681. doi: 10.1038/nrurol.2013.272. Epub 2013 Nov 19.
Abstract | Related citations

*

Yu O, Eberg M, Benayoun S, Aprikian A, Batist G, Suissa S, Azoulay L.
Use of Statins and the Risk of Death in Patients With Prostate Cancer.
J Clin Oncol. 2013 Nov 4. [Epub ahead of print]
Abstract | Full text | Related citations


Survival

*

Redaniel MT, Martin RM, Gillatt D, Wade J, Jeffreys M.
Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study.
BMC Cancer. 2013 Nov 27;13(1):559. [Epub ahead of print]
Abstract | Full text | Related citations

LOCALIZED PROSTATE CANCER


Functional outcomes

Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, Chevallier D, Krajka K, Henneges C, Dickson R, Büttner H.
Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT).
Eur Urol. 2013 Oct 13. pii: S0302-2838(13)01054-3. doi: 10.1016/j.eururo.2013.09.051. [Epub ahead of print]
Abstract | Full text | Related citations


Oncologic outcomes

Sundi D, Wang VM, Pierorazio PM, Han M, Bivalacqua TJ, Ball MW, Antonarakis ES, Partin AW, Schaeffer EM, Ross AE.
Very-high-risk localized prostate cancer: definition and outcomes.
Prostate Cancer Prostatic Dis. 2013 Nov 5. doi: 10.1038/pcan.2013.46. [Epub ahead of print]
Abstract | Full text | Related citations


Survival

Fosså SD, Nilssen Y, Kvåle R, Hernes E, Axcrona K, Møller B.
Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the norwegian experience.
Urology. 2014 Jan;83(1):146-53. doi: 10.1016/j.urology.2013.08.081. Epub 2013 Nov 12.
Abstract | Related citations

 

Treatment

Paller CJ, Antonarakis ES, Eisenberger MA, Carducci MA.
Management of patients with biochemical recurrence after local therapy for prostate cancer.
Hematol Oncol Clin North Am. 2013 Dec;27(6):1205-19, viii. doi: 10.1016/j.hoc.2013.08.005. Epub 2013 Sep 18.
Abstract | Related citations


Treatment comparison

Hoffman RM, Penson DF, Zietman AL, Barry MJ.
Comparative effectiveness research in localized prostate cancer treatment.
J Comp Eff Res. 2013 Nov;2(6):583-93. doi: 10.2217/cer.13.66.
Abstract | Full text | Related citations

*

Merino T, San Francisco IF, Rojas PA, Bettoli P, Zúñiga A, Besa P.
Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up.
BMC Cancer. 2013 Nov 8;13(1):530. [Epub ahead of print]
Abstract | Full text | Related citations

ADVANCED PROSTATE CANCER


 Survival

Wu JN, Fish KM, Evans CP, Devere White RW, Dall'era MA.
No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period.
Cancer. 2013 Nov 20. doi: 10.1002/cncr.28485. [Epub ahead of print]
Abstract | Related citations